Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of GSK2894512 Cream in Healthy Adults
NCT03201978Phase 1Withdrawn
- Sponsor
- GSK
- Start
- Dec 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in psoriasis and atopic dermatitis (AD) comparing GSK2894512 cream group with Vehicle cream group (2 arms). Primary endpoints: Plasma concentrations of GSK2894512 (trans-isomer), Area under the plasma concentration-time curve from time zero to the end of the dosing interval and 6 more. Planned start Dec 2017; status: withdrawn.
02
Drugs
tapinarof
03
Conditions
psoriasisatopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03201978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201978.